Dr Gordon Campbell
Ph.D., Swinburne University, Australia; • Master of Marketing , Monash University, Australia; • Bachelor of Commerce , University of Melbourne, Australia
Gordon is a Lecturer in Marketing at Swinburne University of Technology, Melbourne, Australia. Prior to joining Swinburne, Gordon had an extensive career as a marketing executive with the Eastman Kodak Company in Australia and Asia.
Gordon is a qualitative ethnographic researcher specialising in gay men’s health, public health, epidemiology, health behaviours and consumer behaviour.
Gordon was awarded his PhD in September 2018. The Thesis describes his study of the development of gay men's attitudes, behaviours and loyalties regarding safe/unsafe sex. In his study Gordon collected and analysed the autobiographical life histories of 16 gay men using the Narrative Inquiry method. The Contributions to knowledge are in the areas of social marketing and the psychology of health behaviours. His research leveraged his academic and business experience in marketing (the development and modification of attitudes and behaviours) with his lived experience as a gay man and as a voluntary carer and care leader for People Living with HIV.
Current Research Project; Gordon is the qualitative ethnographic researcher attached to the TITAN Project.
Project Manager; Associate Professor James McMahon, Head of Clinical Research and Infectious Diseases Physician, Alfred Health and Monash University.
- The TITAN Trial is a global collaboration between researchers at University of Aarhus in Denmark, The Alfred Hospital and the Doherty Institute in Melbourne.
- Looking at the effect of an immune stimulating treatment drug combined with antibodies designed to target HIV.
- Exploring the impacts of the immune stimulating drug Lefitolimod, a toll-like receptor 9 agonist combined with broadly neutralizing antibodies 3BNC117 and 10-1074 on HIV specific immune responses.
- Background to Gordon’s study in 2022: Clinical studies investigating strategies to cure HIV are increasingly using analytical treatment interruptions (ATI), or closely monitored pauses in antiretroviral therapy (ART), to test the intervention. Little is known about the motivations and experiences of participants in these trials. This study aimed to understand perspectives of participants during an HIV cure-related clinical trial conducted in Melbourne.
Gordon is authorised as Principal Supervisor for Masters and PhD students.
Social impact; Brand Loyalty, Management of public health and social issue behaviours.
PhD candidate and honours supervision
Higher degrees by research
Accredited to supervise Masters & Doctoral students as Principal Supervisor.
Available to supervise honours students.
Fields of Research
- Marketing - 350600
Marketing; Management, Consumer Behaviour, Fundamentals.
- 2014, Swinburne, Teaching Excellence Award, Faculty of Business and Law, Swiburne University of Technology
- 2009, Swinburne, Corporate Citizenship Award, Faculty of Business and Enterprise, Swiburne University of Technology
- 2000 (current): Committee Member, Motafrenz Car Club (GLBITQ), Australia
- 2010 - 2012: President, Motafrenz Car Club (GLBITQ), Australia
- 2008 (current): Chair, Victorian AIDS Council, Area Leader for Richmond Group, Community Support Program, Australia
- 1994 (current): Life Member, Victorian AIDS Council, Australia
- 2000 (current): Life Member, Motafrenz Car Club (GLBITQ), Australia
- 2008 (current): Member, The Australian Market and Social Research Society, Australia
- 1990 (current): Fellow, Australian Marketing Institute, Certified Practising Marketer, Australia
Also published as: Campbell, Gordon; Campbell, G.; Campbell, G. E.; Campbell, Gordon E.
This publication listing is provided by Swinburne Research Bank. If you are the owner of this profile, you can update your publications using our online form.
There are no grants to display.
There are no media items to display